The store will not work correctly when cookies are disabled.
Isoxazol-5-yl-(5-mercapto-3-methyl-1-phenyl-1H-pyrazol-4-yl)methanone
ID: ALA2377167
PubChem CID: 71580587
Max Phase: Preclinical
Molecular Formula: C14H11N3O2S
Molecular Weight: 285.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1nn(-c2ccccc2)c(S)c1C(=O)c1ccno1
Standard InChI: InChI=1S/C14H11N3O2S/c1-9-12(13(18)11-7-8-15-19-11)14(20)17(16-9)10-5-3-2-4-6-10/h2-8,20H,1H3
Standard InChI Key: AZSNZHGERBFBJT-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
15.2528 -15.2377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2517 -16.0572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9597 -16.4662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6694 -16.0568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6666 -15.2341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9579 -14.8288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9560 -14.0117 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6157 -13.5294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3612 -12.7529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5436 -12.7554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2935 -13.5333 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0612 -12.0957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3936 -13.7796 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
16.7676 -12.0436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5848 -12.0413 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.2938 -11.3778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5495 -10.6023 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.8931 -10.1155 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.2273 -10.5893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4723 -11.3689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 7 1 0
6 7 1 0
10 12 1 0
8 13 1 0
9 14 1 0
14 15 2 0
14 16 1 0
16 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 16 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 285.33 | Molecular Weight (Monoisotopic): 285.0572 | AlogP: 2.69 | #Rotatable Bonds: 3 |
Polar Surface Area: 60.92 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.29 | CX Basic pKa: 1.63 | CX LogP: 2.12 | CX LogD: 0.77 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.59 | Np Likeness Score: -1.69 |
References
1. Purohit MK, Scovell I, Neschadim A, Katsman Y, Branch DR, Kotra LP.. (2013) Disulfide linked pyrazole derivatives inhibit phagocytosis of opsonized blood cells., 23 (8): [PMID:23489619] [10.1016/j.bmcl.2013.02.064] |